Now ready to order!    ▶

SYNTAX System:
The world’s first DNA printer powered by EDS

Powered by Enzymatic DNA Synthesis (EDS), the SYNTAX System puts you in control of DNA oligo production. Create custom DNA oligos that are ready to use the same day you need them.
DISCOVER THE POWER OF SYNTAX
Accessible
  • On-demand, in-house oligo production
  • No specialized training or skills required
  • Simple and safe
Convenient, Fast, and Flexible
  • Update or modify designs in minutes with plug-and-play workflows
  • Produce variable DNA oligo lengths and batch sizes
  • Micromolar scale supports single use and rapid iteration
Full Control from Sequence to Application
  • Improved control over sequence information and security
  • Freedom from delays or backorders
  • Accelerate innovation and reduce hidden project costs
FEATURED COLLABORATION

See how our EDS technology is being leveraged to deploy vaccines as part of DARPA NOW.
Learn More  ▶
FEATURED APPLICATION

See how primers produced using our EDS technology were used for sequencing and analysis of SARS-CoV-2.
Learn More  ▶

See how we’re revolutionizing biological research

DNA Script Appoints Marc Montserrat as CEO to Drive Long-Term Commercial Growth for Groundbreaking Enzymatic DNA Synthesis Platform
MEDIA COVERAGE
DNA Script Appoints Marc Montserrat as CEO to Drive Long-Term Commercial Growth for Groundbreaking Enzymatic DNA Synthesis Pla…
Founding CEO Thomas Ybert transitions to Chief Scientific Officer role to underscore company’s ongoing commitment to scientific discovery and innovation PARIS and DALY CITY, Calif. – DNA Script, a leader in enzymatic DNA synthesis, … Learn More  ▶
Syntax
PRESS RELEASE
DNA Script to Unveil Industry’s Most Versatile On-site, On-Demand DNA Printer at the World’s Largest Synthetic Biology Confere…
Fully automated SYNTAX platform features latest STX-200 system, enzymatic biochemistry advances, and ready-to-use reagents for producing up to 96 oligos … Learn More  ▶
READ THE LATEST NEWS

The technology

Enzymatic DNA Synthesis (EDS) offers significant advantages in accessibility and convenience, transforming the pace of and control over custom DNA oligo production, with reduced environmental impact over traditional outsourced, chemical-based synthesis.
LEARN MORE ABOUT EDS

Applications in molecular biology, genomics, and more

See how industry leaders are using our SYNTAX Platform to power discoveries in genomics, personalized medicine, and beyond.
VIEW APPLICATIONS